The Pediatric Oncology group is dedicated to the care of children with cancer and to the cure of cancer in children. UPCI research teams at Children's Hospital of Pittsburgh of UPMC are actively involved in clinical hematology and oncology research, as well as basic research in the areas of cancer etiology, immunology, stem cell biology, and molecular oncology. Expert clinicians within the fields of oncology, neuro-oncology, coagulation, and stem cell transplantation are dedicated to providing excellent patient care to children with cancer, and the program also has a commitment to the educational training of future pediatricians and pediatric hematologists/oncologists through its activity in the pediatric residency and pediatric hematology/oncology fellowship programs.
Children's Hospital is a longtime member of the Children's Oncology Group (COG), the National Cancer Institute (NCI)-sponsored pediatric oncology trials group. Many physicians at Children's are leaders in the COG and are active in developing new cancer treatment strategies, thereby ensuring that Children's offers state-of-the-art therapy to children with all forms of childhood cancer. Children's is among only 20 COG-member institutions in the country eligible to perform Phase I clinical trials, which enables Children's to offer
patients the newest experimental drugs and treatments.
For more information on pediatric cancers, visit the UPMC Division of Pediatric Hematology/Oncology website.